Insomnia

The ability to finally enjoy a good night's sleep is something that can be learned. An Austrian Science Fund FWF project has investigated how this can best be learned and who responds best to such "brain training". Dark circles around the eyes, tired limbs, absent-mindedness – most people have exp more

A connection between persistent insomnia and increased inflammation and mortality has been identified by a group of researchers from the University of Arizona. Their study, published in The American Journal of Medicine, found that people who suffer from persistent insomnia are at greater risk than t more

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a review of zolpidem-containing medicines, used for the short-term treatment of insomnia (inability to sleep). The benefit-risk balance of these medicines remains positive, but the PRAC recommended chang more

The mystery illness first reported in late 2016 among U.S. diplomats in Havana is now affecting personnel at a U.S. consulate in Guangzhou, China. Yet 18 months in, an explanation is nowhere in sight, although hypotheses have proliferated. Former Secretary of State Rex Tillerson blamed a deliberate more

Insomnia is a worldwide problem with substantial deleterious health effects. Twin studies have shown a heritable basis for various sleep-related traits, including insomnia, but robust genetic risk variants have just recently begun to be identified. We conducted genome-wide association studies (GWAS) more

Insomnia linked to premature birth in study of 3 million mothers Nature 548, 7666 (2017). http://www.nature.com/doifinder/10.1038/nature.2017.22419 Author: Amy Maxmen Women with sleep disorders were about twice as likely to deliver b more

Introduction Global Markets Direct’s, 'Insomnia - Pipeline Review, H2 2012', provides an overview of the Insomnia therapeutic pipeline. This report provides information on the therapeutic development for Insomnia, complete with latest updates, and special features on late-stage and discontinued pr more

Introduction Global Markets Direct’s, 'Insomnia - Pipeline Review, H1 2012', provides an overview of the Insomnia therapeutic pipeline. This report provides information on the therapeutic development for Insomnia, complete with latest updates, and special features on late-stage and discontinued pr more

Introduction Global Markets Direct’s, 'Insomnia - Pipeline Review, Q1 2011', provides an overview of the Insomnia therapeutic pipeline. This report provides information on the therapeutic development for Insomnia, complete with latest updates, and special features on late-stage and discontinued pro more